Apple, drugs, Grindr

This podcast episode explores the recent news surrounding Apple's market value drop in China, the US government's negotiations with drug companies for Medicare Part D recipients, the potential impact of these negotiations on drug prices, and the aftermath of the return-to-office policy implemented by Grindr, which resulted in significant layoffs. It highlights the challenges Apple faces in China, the government's first-time negotiation with drug makers, the potential penalties and new prices for drugs, the allegations of labor law violations by Grindr, and the unionization effort by Grindr employees.